Specialty Pharmacy

Study finds that drop in support for health care spending is attributable to the Affordable Care Act, not the recession.

Study examines the potential impact from GLP-1 agonists, or incretin mimetics to treat diabetes.

Researchers examine the correlation between vitamin D levels and MS risk in African Americans or Hispanics.

Ex-vivo lung perfusion keeps the lung alive, breathing outside the body and supported by a supply of blood and nutrients.

Shortened telomere length may help inhibit cancer, but it is also associated with the progression of aging in humans.

Agreement represents the largest regional trade accord in history, which could have wide ranging impact on health care.

Roche has launched a new HbA1C test to identify diabetes risk and diagnose and monitor patients with diabetes.

Inhibiting the protein PARP 14 shows promise in stopping uncontrolled cancer cell growth.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses significant challenges in over the next five years in specialty pharmacy.

Cladribine was previously denied market authorization on the suspicion that it may cause cancer.

Patients should be closely monitored by proper diagnostic methods.

The FDA has accepted Sandoz's Biologics License Application (BLA) for its proposed etanercept (Enbrel) biosimilar.

Study finds inhibition of the NOTCH4 signal may be a promising target to prevent the growth and spread of cancer.

Novel method may reduce the length of treatment time and decrease side effects.

Arava can reduce RA symptoms and slow down associated structural damage.

Medication therapy management could improve health care outcomes for patients and lower overall costs.

Keytruda treats patients with metastatic non-small cell lung cancer whose disease has progressed despite other treatment methods.

Guidelines include risk classification system to remind caregivers to examine diabetics' feet.

Therapy with binimetinib and ribociclib shows significant clinical activity in NRAS-mutant melanoma patients.

The latest stabbing of a pharmacist has renewed calls for tougher sentencing and increased policing to protect pharmacists.

Medication dispensing within the first few months of prescribing chronic therapy can precisely predict future patient adherence.

Viral induction greater than any other latency reversing agent.

Top cancer-related news from the past week.

New guidelines based on overwhelming clinical evidence that ART is effective.

Economic development and urbanization factors influence cancer incidence growth.

Around 11% of patients who use insulin have adverse drug reactions.

A pharmacist in Nebraska has pleaded guilty to what is possibly the largest case of Medicaid fraud in the state.

Hepatitis C infections are more likely to become persistent and to lead to progressive liver disease in patients with HIV.